For more on split dosing rationale, our tirzepatide efficacy timeline discusses how splitting affects onset patterns
BPC-157 is thought to work through several mechanisms, including: Upregulation of growth hormone receptors in tendon and muscle tissue Promotion of angiogenesis (new blood vessel formation) Modulation of nitric oxide pathways to support tissue perfusion Anti-inflammatory effects via interaction with the dopaminergic and serotonergic systems Direct cytoprotective effects on the gut lining TB-500 (Thymosin Beta-4 Synthetic Fragment) TB-500 is a synthetic analogue of Thymosin Beta-4 (T4), a naturally occurring peptide found throughout the human body, with especially high concentrations in platelets, wound fluid, and areas of active tissue repair
doi: 10.1093/ckj/sfae018
What is new is the growing pile of evidence suggesting that activating those receptors, even at very low doses, can quiet the overactive immune response that defines conditions like rheumatoid arthritis , psoriasis, Hashimoto thyroiditis, and inflammatory bowel disease
Increased tear osmolarity in dry eye disease has been found to stimulate production of inflammatory cytokines and matrix metalloproteinases by ocular surface epithelial cells [155]
Most effects are mild and short-lived
